Année 2013

Characterization of seven novel mutations on the HEXB gene in French Sandhoff patients.
Gaignard P, Fagart J, Niemir N, Puech JP, Azouguene E, Dussau J, Caillaud C.
Gene. 2013 Jan 10;512(2):521-6.

Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.
Turpin E, Muscat A, Vatier C, Chetrite G, Corruble E, Moldes M, Fève B.
Br J Pharmacol. 2013 Jan;168(1):139-50.

Two Families with Normosmic Congenital Hypogonadotropic Hypogonadism and Biallelic Mutations in KISS1R (KISS1 Receptor): Clinical Evaluation and Molecular Characterization of a Novel Mutation.
Brioude F, Bouligand J, Francou B, Fagart J, Roussel R, Viengchareun S, Combettes L, Brailly-Tabard S, Lombès M, Young J, Guiochon-Mantel A.
PLoS One. 2013;8(1):e53896.

The mineralocorticoid signaling pathway throughout development: Expression, regulation and pathophysiological implications.

Martinerie L, Munier M, Le Menuet D, Meduri G, Viengchareun S, Lombès M.
Biochimie. 2013 Feb;95(2):148-57.

Computed Tomography of the Anterior Skull Base in Kallmann Syndrome Reveals Specific Ethmoid Bone Abnormalities Associated With Olfactory Bulb Defects.
Maione L, Benadjaoud S, Eloit C, Sinisi AA, Colao A, Chanson P, Ducreux D, Benoudiba F, Young J.
J Clin Endocrinol Metab. 2013 Mar;98(3):E537-46.

Tissu adipeux brun
Renaissance et nouvelles perspectives thérapeutiques dans l’obésité et le diabète
Kuhn E, Lombès M
Diabète & Obésité , 2013 (8)65, 2-6

Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.
Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D.
Pituitary. 2014 Feb;17(1):81-9.

Frequent Large Germline HRPT2 Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism.
Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L; the GTE Group.
J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8.

A man with a DAX1/NR0B1 mutation, normal puberty and an intact hypothalamic-pituitary-gonadal axis but deteriorating oligospermia during long-term follow-up.
Raffin-Sanson ML, Oudet B, Salenave S, Brailly-Tabard S, Pehuet M, Christin-Maitre S, Morel Y, Young J.
Eur J Endocrinol. 2013 Mar 15;168(4):K45-50.

[Hyperprolactinemia and infertility: a new physiopathological approach].
Sonigo C, Young J, Binart N.
Med Sci (Paris). 2013 Mar;29(3):242-4.

Ovarian function is restored after grafting of cryopreserved immature ovary in ewes.

Sauvat F, Bouilly J, Capito C, Lefèvre A, Blachère T, Borenstein N, Sarnacki S, Dandolo L, Binart N.
Faseb J. 2013 Apr;27(4):1511-8.

Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
Bellance C, Khan JA, Meduri G, Guiochon-Mantel A, Lombès M, Loosfelt H.
Mol Biol Cell. 2013 May;24(9):1363-1374.

NR5A1 (SF-1) Mutations Are Not a Major Cause of Primary Ovarian Insufficiency.
Voican A, Bachelot A, Bouligand J, Francou B, Dulon J, Lombès M, Touraine P, Guiochon-Mantel A.
J Clin Endocrinol Metab. 2013 May;98(5):E1017-21.

An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.
Blanchard A, Steichen O, De Mota N, Curis E, Gauci C, Frank M, Wuerzner G, Kamenicky P, Passeron A, Azizi M, Llorens-Cortes C.
J Clin Endocrinol Metab. 2013 May;98(5):2084-9.

Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells.
Hescot S, Slama A, Lombès A, Paci A, Remy H, Leboulleux S, Chadarevian R, Trabado S, Amazit L, Young J, Baudin E, Lombès M.
Endocr Relat Cancer. 2013 May 21;20(3):371-381.

A New Strategy for Selective Targeting of Progesterone Receptor with Passive Antagonists.
Khan JA, Tikad A, Fay M, Hamze A, Fagart J, Chabbert-Buffet N, Meduri G, Amazit L, Brion JD, Alami M, Lombès M, Loosfelt H, Rafestin-Oblin ME.
Mol Endocrinol. 2013 Jun;27(6):909-24.

A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: The French 3C cohort study.
Soisson V, Brailly-Tabard S, Helmer C, Rouaud O, Ancelin ML, Zerhouni C, Guiochon-Mantel A, Scarabin PY.
Maturitas. 2013 Jul;75(3):282-8.

R31C GNRH1 Mutation and Congenital Hypogonadotropic Hypogonadism.
Maione L, Albarel F, Bouchard P, Gallant M, Flanagan CA, Bobe R, Cohen-Tannoudji J, Pivonello R, Colao A, Brue T, Millar RP, Lombes M, Young J, Guiochon-Mantel A, Bouligand J.
PLoS One. 2013 Jul 25;8(7):e69616.

Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patients.
Vija L, Meduri G, Comperat E, Vasiliu V, Izard V, Ferlicot S, Boukari K, Camparo P, Viengchareun S, Constancis E, Dumitrache C, Lombès M, Young J.
Mol Cell Endocrinol. 2013 Aug 15;375(1-2):140-8.

Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis.
Adán N, Guzmán-Morales J, Ledesma-Colunga MG, Perales-Canales SI, Quintanar-Stéphano A, López-Barrera F, Méndez I, Moreno-Carranza B, Triebel J, Binart N, Martínez de la Escalera G, Thebault S, Clapp C.
J Clin Invest. 2013 Sep 3;123(9):3902-13.

Prolactin is not required for the development of severe chronic experimental autoimmune encephalomyelitis.
Costanza M, Musio S, Abou-Hamdan M, Binart N, Pedotti R.
J Immunol. 2013 Sep 1;191(5):2082-8.

[Aggressive and resistant-to-treatment pituitary tumors].
Cuny T, Chanson P.
Ann Endocrinol (Paris). 2013 Oct;74 Suppl 1:S3-12.

[Targeted therapies, prognostic and predictive factors in endocrine oncology].
Hescot S, Baudin E, Borson-Chazot F, Lombès M.
Ann Endocrinol (Paris). 2013 Oct;74 Suppl 1:S13-22.

Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis.
Moreno-Carranza B, Goya-Arce M, Vega C, Adán N, Triebel J, López-Barrera F, Quintanar-Stéphano A, Binart N, Martínez de la Escalera G, Clapp C.
Am J Physiol Regul Integr Comp Physiol. 2013 Oct 1;305(7):R720-6.

Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.
De Martino MC, Al Ghuzlan A, Aubert S, Assié G, Scoazec JY, Leboulleux S, Do Cao C, Libè R, Nozières C, Lombès M, Pattou F, Borson-Chazot F, Hescot S, Mazoyer C, Young J, Borget I, Colao A, Pivonello R, Soria JC, Bertherat J, Schlumberger M, Lacroix L, Baudin E.
J Clin Endocrinol Metab. 2013 Oct;98(10):4080-8.

The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A, Carré N, Mialon O, Matelot M, Servel N, Monget P, Ahtiainen P, Huhtaniemi I, Binart N.
Am J Physiol Endocrinol Metab. 2013 Oct 1;305(7):E845-52.

Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia.
Louiset E, Duparc C, Young J, Renouf S, Tetsi Nomigni M, Boutelet I, Libé R, Bram Z, Groussin L, Caron P, Tabarin A, Grunenberger F, Christin-Maitre S, Bertagna X, Kuhn JM, Anouar Y, Bertherat J, Lefebvre H.
N Engl J Med. 2013 Nov 28;369(22):2115-25.

Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period.
Auffret J, Freemark M, Carré N, Mathieu Y, Tourrel-Cuzin C, Lombès M, Movassat J, Binart N.
Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1309-18.

Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren’s syndrome.
Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Ma A, Busato F, Melki J, Lessard CJ, Sivils KL, Dubost JJ, Hachulla E, Gottenberg JE, Lombès M, Tost J, Criswell LA, Mariette X.

Blood. 2013 Dec 12;122(25):4068-76